S-8 S-8 EX-FILING FEES 0002139097 TRex Bio, Inc. N/A Fees to be Paid Fees to be Paid Fees to be Paid 0002139097 2026-10-08 2026-10-08 0002139097 1 2026-10-08 2026-10-08 0002139097 2 2026-10-08 2026-10-08 0002139097 3 2026-10-08 2026-10-08 iso4217:USD xbrli:pure xbrli:shares

Calculation of Filing Fee Tables

S-8

TRex Bio, Inc.

Table 1: Newly Registered Securities

Security Type

Security Class Title

Fee Calculation Rule

Amount Registered

Proposed Maximum Offering Price Per Unit

Maximum Aggregate Offering Price

Fee Rate

Amount of Registration Fee

1 Equity TRex Bio, Inc. 2024 Equity Incentive Plan - Common Stock, $0.0001 par value per share Other 2,848,269 $ 1.23 $ 3,503,370.87 0.000087 $ 304.79
2 Equity TRex Bio, Inc. 2026 Equity Incentive Plan - Common Stock, $0.0001 par value per share Other 2,757,753 $ 15.00 $ 41,366,295.00 0.000087 $ 3,598.87
3 Equity TRex Bio, Inc. 2026 Employee Stock Purchase Plan - Common Stock, $0.0001 par value per share Other 275,775 $ 15.00 $ 4,136,625.00 0.000087 $ 359.89

Total Offering Amounts:

$ 49,006,290.87

$ 4,263.55

Total Fee Offsets:

$ 0.00

Net Fee Due:

$ 4,263.55

Offering Note

1

(1) Pursuant to Rule 416 under the Securities Act of 1933, as amended (the "Act") this Registration Statement also covers such additional shares of common stock, par value $0.0001 per share ("Common Stock") as may be issued to prevent dilution from stock splits, stock dividends and similar transactions. (2) Represents shares of Common Stock issuable upon exercise or settlement of awards previously granted under the TRex Bio, Inc. 2024 Equity Incentive Plan (the "2024 Plan") that are outstanding as of the date of this Registration Statement. (3) Estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(h) under the Act. For the shares of Common Stock reserved for issuance upon the exercise of outstanding awards under the 2024 Plan, the Proposed Maximum Offering Price Per Share is $1.22 per share, which is the weighted average exercise price (rounded to the nearest cent) of the outstanding awards under the 2024 Plan.

2

(1) Pursuant to Rule 416 under the Securities Act of 1933, as amended (the "Act") this Registration Statement also covers such additional shares of common stock, par value $0.0001 per share ("Common Stock") as may be issued to prevent dilution from stock splits, stock dividends and similar transactions. (4) Represents shares of Common Stock reserved for issuance under the 2026 Plan (inclusive of shares subject to awards granted under the 2026 Plan prior to the date hereof). The 2026 Plan includes an "evergreen" provision, which provides that on January 1st of each year beginning in 2027 and continuing through and including 2036, the number of shares of Common Stock available for issuance under the 2026 Plan will automatically increase in an amount equal to the lesser of (A) five percent of the number of shares of Common Stock outstanding as of such date and (B) the number of shares of Common Stock determined by the board of directors of the Registrant on or prior to such date for such year. (5) Estimated solely for the purpose of calculating the registration fee in accordance with Rule 457(h) under the Securities Act. The proposed maximum offering price per share and the proposed maximum aggregate offering price are based on the initial public offering price of the Common Stock of $15.00 per share, as set forth in the Registrant's Registration Statement on Form S-1 (File No. 333-299018), as amended (the "S-1 Registration Statement"), that was declared effective on October 8, 2026.

3

(1) Pursuant to Rule 416 under the Securities Act of 1933, as amended (the "Act") this Registration Statement also covers such additional shares of common stock, par value $0.0001 per share ("Common Stock") as may be issued to prevent dilution from stock splits, stock dividends and similar transactions. (5) Estimated solely for the purpose of calculating the registration fee in accordance with Rule 457(h) under the Securities Act. The proposed maximum offering price per share and the proposed maximum aggregate offering price are based on the initial public offering price of the Common Stock of $15.00 per share, as set forth in the Registrant's Registration Statement on Form S-1 (File No. 333-299018), as amended (the "S-1 Registration Statement"), that was declared effective on October 8, 2026. (6) Represents shares of Common Stock reserved for issuance under the TRex Bio, Inc. 2026 Employee Stock Purchase Plan (the "ESPP"). The ESPP includes an "evergreen" provision, which provides that on January 1st of each year beginning in 2027 and continuing through and including 2036, the number of shares of Common Stock available for issuance under the ESPP will automatically increase in an amount equal to the lesser or (A) one percent of the number of shares of Common Stock outstanding as of such date and (B) the number of shares of Common Stock determined by the board of directors of the Registrant on or prior to such date for such year, up to a maximum of 3,033,529 shares in the aggregate per year.
Table 2: Fee Offset Claims and Sources ☑Not Applicable
Registrant or Filer Name Form or Filing Type File Number Initial Filing Date Filing Date Fee Offset Claimed Security Type Associated with Fee Offset Claimed Security Title Associated with Fee Offset Claimed Unsold Securities Associated with Fee Offset Claimed Unsold Aggregate Offering Amount Associated with Fee Offset Claimed Fee Paid with Fee Offset Source
Rule 457(p)
Fee Offset Claims
Fee Offset Sources